Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle plk'

Search results for: 'research area cell cycle plk'

Items 91-100 of 155

Page
per page
  1. YM201636
    B2189 YM201636
    Target: PIKfyve
    Summary: PIKfyve inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥11.68 mg/mL
  2. Mechlorethamine HCl
    B1785 Mechlorethamine HCl
    Summary: DNA synthesis inhibitor
  3. Z-YVAD-FMK
    A8955 Z-YVAD-FMK
     7 Citation
    Target: Caspases
    Summary: Caspase-1 inhibitor
      ≥31.55 mg/mL
  4. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  5. Elesclomol (STA-4783)
    A4386 Elesclomol (STA-4783)
     3 Citation
    Summary: Oxidative stress/apoptosis inducer,potent and novel
      insoluble in H2O; ≥20.15 mg/mL
  6. Nocodazole
    A8487 Nocodazole
     1 Citation
    Target: Microtubules/Tubulins
    Summary: Tubulin production inhibitor,anti-neoplastic agent
      insoluble in H2O; insoluble in EtOH; ≥15.066 mg/mL
  7. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  8. BMS-833923
    A3258 BMS-833923
    Target: Smoothened
    Summary: Smoothened inhibitor
      ≥47.4 mg/mL
  9. Sitagliptin phosphate monohydrate
    A4036 Sitagliptin phosphate monohydrate
     5 Citation
    Target: DPP-4
    Summary: Potent DPP-4 inhibitor
      ≥23.8 mg/mL
  10. Dorsomorphin (Compound C)
    B3252 Dorsomorphin (Compound C)
     5 Citation
    Target: AMPK
    Summary: AMPK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥8.49 mg/mL

Items 91-100 of 155

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 151item
  2. Natural Products 1 item
  3. Kits 1 item
  4. Lab Reagents 2item
Reversibility
  1. Reversible 16item
  2. Irreversible 5item
Target
  1. Caspases 4item
  2. Cyclin-Dependent Kinases 11item
  3. Proteasome 4item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 10item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 3item
  10. Raf 1 item
  11. Aurora Kinases 1 item
  12. Glycoproteins 1 item
  13. MDM2 1 item
  14. EZH2 1 item
  15. mTOR 1 item
  16. AP-1 2item
  17. MMP 1 item
  18. Myosin II ATPases 1 item
  19. FLT3 1 item
  20. GSK-3 4item
  21. LPA Receptors 1 item
  22. P-glycoprotein (P-gp) 3item
  23. PLK 3item
  24. Chk 4item
  25. VEGFR 1 item
  26. PDGFR 2item
  27. c-Kit 1 item
  28. Bromodomain-containing proteins(BRDs) 1 item
  29. Phosphodiesterases (PDEs) 1 item
  30. Hydrolase 1 item
  31. p38 1 item
  32. MEK 1 item
  33. PORCN 1 item
  34. DOT1L 1 item
  35. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  36. Smoothened 2item
  37. Eukaryotic elongation factors 1 item
  38. Ras 1 item
  39. Trk Receptors 1 item
  40. STAT 2item
  41. Microtubules/Tubulins 4item
  42. EGFR 4item
  43. Hedgehog 1 item
  44. ROCK 4item
  45. JAK 2item
  46. p300 1 item
  47. Syk 1 item
  48. DNA-PK 1 item
  49. HSP90 1 item
  50. AMPK 2item
  51. CFTR 3item
  52. TNKS 1 item
  53. ErbB 2item
  54. Toll-like receptors (TLRs) 1 item
  55. DNA Methyltransferases 1 item
  56. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  57. ERK 1 item
  58. BMI-1 1 item
  59. PKC 1 item
  60. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  61. Lyn 1 item
  62. SGLT 1 item
  63. LRRK2 1 item
  64. Sphingosine kinases (SphKs) 1 item
  65. Fatty-acid-binding proteins (FABPs) 1 item
  66. Tie-2 1 item
  67. Free Fatty Acid Receptors 1 item
  68. phosphatases 1 item
  69. Autophagy 2item
  70. ATM/ATR 2item
  71. Farnesyl Diphosphate Synthases 1 item
  72. Melatonin Receptors 1 item
  73. Peroxynitrite 1 item
  74. MAGL 1 item
  75. NPY Receptors 1 item
  76. Histamine H1 Receptors 2item
  77. TRP Channel 1 item
  78. NO Donors / Precursors 1 item
  79. IL Receptors 1 item
  80. 15-lipoxygenases 1 item
  81. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  82. Aldosterone receptor 1 item
  83. DPP-4 1 item
  84. DREADD Ligands 1 item
  85. p53-MDM2 interaction 1 item
  86. c-Fms tyrosine kinase 1 item
  87. Ub-conjugating enzyme (E2) complex 1 item
  88. DCLK2 1 item
  89. Bcl-w 1 item
  90. FXR 1 item
  91. Sirtuin 1 item
  92. PIKfyve 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 7item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 4item
  5. B-lymphoid Malignancies 1 item
  6. Breast Cancer 30item
  7. Cancer 92item
  8. Cholangiocarcinoma 1 item
  9. Chronic Lymphocytic Leukemia 2item
  10. Colon Cancer 11item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 13item
  13. Diabetes 2item
  14. Fungal Infection 1 item
  15. Glioblastoma 7item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 3item
  18. Immunosuppressive Therapy 1 item
  19. Inflammatory Diseases 4item
  20. Leukemia 5item
  21. Liver Cancer 2item
  22. Lung Cancer 5item
  23. Lymphoma 4item
  24. Mantle Cell Lymphoma 2item
  25. Medulloblastoma 1 item
  26. Melanoma 11item
  27. Mixed Lineage Leukemia 1 item
  28. Multiple Myeloma 5item
  29. Neuroblastoma 2item
  30. Non-small Cell Lung Cancer 5item
  31. Non-small Cell Lung Carcinoma 1 item
  32. Ovarian Cancer 9item
  33. Pain Relief 1 item
  34. Pancreatic Cancer 11item
  35. Pancreatic Carcinoma 2item
  36. Prostate Cancer 12item
  37. Psoriasis 1 item
  38. Pulmonary Fibrosis 1 item
  39. Renal Cell Carcinoma 2item
  40. Rheumatoid Arthritis 2item
  41. Sleep Disorders 1 item
  42. Type 2 Diabetes 3item